Global Automated Nucleic Acid Extraction Systems Industry is expected to grow at a 10.9% CAGR and be valued US$11.32 Billion By 2032 | FMI

Global Automated Nucleic Acid Extraction Systems Industry
Global Automated Nucleic Acid Extraction Systems Industry

The Global Automated Nucleic Acid Extraction Systems Industry is on track for a significant expansion, fueled by the increasing demand for efficient and accurate genetic analysis. According to a recent forecast by Future Market Insights (FMI), a leading market research firm, the market is projected to surge at a compelling Compound Annual Growth Rate (CAGR) of 10.9% from 2022 to 2032. This impressive growth trajectory signifies a substantial market expansion, with the valuation anticipated to reach a staggering US$11.32 billion by 2032.

Automated nucleic acid extraction systems are at the forefront of this revolutionary expansion, providing fast, clean, and consistently improved nucleic acid extraction procedures. Their critical significance in nucleic acid purification, along with significant contributions to personalized and predictive medicine, highlights the increasing need for these cutting-edge technologies.

The projected growth of the industry represents a paradigm shift in nucleic acid extraction methodologies. With an escalating focus on efficiency and precision, automated systems have become the cornerstone of laboratories and research facilities worldwide. Their unparalleled ability to streamline processes not only accelerates research but also ensures the reliability of results.

Request a Sample of this Report Now Use Work Email To Get Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5414

These systems are designed in such a way that they efficiently run multiple processes at the same time with a reduced error ratio thereby acting as a major driver in the Global Automated Nucleic Acid Extraction Systems Industry. Furthermore, the rising utilization of automotive procedures in research and development has bolstered the demand for technologically superior automatic nucleic acid extraction systems.

Global Automated Nucleic Acid Extraction Systems Industry Key Takeaways

  • The isolation and the purification in the automated nucleic acid extraction systems fall under the category of fundamental tests in molecular laboratory research which further comprises a vast range of equipment and procedures available for its extraction.
  • Furthermore, user-friendly interfaces are integrated with the systems to further simplify the processes. Moreover, the functionality of these systems comprises shaking, temperature control, and PCR protocols.
  • Automated nucleic acid extraction systems also help in minimizing the contamination in samples, providing high throughput results in comparatively less time and reducing the reagent wastage. Owing to these factors, the global demand for automated nucleic acid extraction systems is on the rise.
  • These systems are vastly employed in molecular biology, pathology, forensic science, environmental research, and drug delivery. Furthermore, these automated systems are known for their advancements in extracting nucleic acid from a variety of samples such as tissue, cell culture, whole blood, serum, plasma, swabs, etc.
  • The nucleic acid extraction system market is predicted to rise steadily as these user–friendly methods reduce sample contamination, provide high throughput results at a rapid pace, and greatly reduce reagent wastage.
  • Surging laboratory automation and widespread adoption of superior technology for faster and better results propels market growth. Furthermore, technological advancements in automated nucleic acid extraction systems in improving the workflow and decreasing variability also support the automated nucleic acid extraction systems market.
  • The high cost of the system, limited product acceptability, high maintenance, system complexity, and service cost are some of the limiting factors restricting potential market growth. In addition to that, low market penetration of automated systems in less developed regions also restricts global market growth.

Global Automated Nucleic Acid Extraction Systems Industry Competitive Landscape

Some of the prominent players in the Global Automated Nucleic Acid Extraction Systems Industry are focusing on technological advancements to attain an edge over the market. Various other regional players are concentrating on collaboration to efficiently cater to the ever-increasing customer demands.

A large number of companies are involved in the rapid manufacturing of such laboratory instruments varying by size, usage, capacity, price, and versatility. These days, most commercial extraction kits are also available in the market in line with automated nucleic acid extraction platforms. Continuous enhancements for the system updating also help in proliferating the market growth for nucleic acid extraction systems.

Several other companies are rapidly adopting strategies for building their networks and strengthening their sales force to increase their product sales. Furthermore, brand value is also considered a vital parameter affecting the sales of a certain company. New product development, mergers, acquisitions, and partnerships are some of the key trends in the Global Automated Nucleic Acid Extraction Systems Industry.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-5414

Global Automated Nucleic Acid Extraction Systems Industry Key Players:

  • Qiagen N.V.
  •  Roche Molecular Systems, Inc.
  •  Analytik Jena AG
  •  Thermofisher Scientific
  • Accubiomed Co., Ltd.
  •  Autogen Inc.
  • DiagCor Bioscience Inc Lt
  •  Taigen Bioscience Corporation
  •  Bioneer Corporation

Global Automated Nucleic Acid Extraction Systems Industry Key Segments:

By Type

  • Instruments
  • Kits and consumables

By End Use

  • Hospitals
  • Diagnostic Centres
  • Forensic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *